Brief: Allena Pharmaceuticals Says Decided To Terminate Urirox-2 Study
18/03/2022 21:24
March 18 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS INC - DECIDED TO TERMINATE URIROX-2
STUDY
* ALLENA PHARMACEUTICALS INC - NO FURTHER CLINICAL STUDIES
OF
RELOXALIASE ARE PLANNED AT THIS TIME
* ALLENA PHARMACEUTICALS INC - COMPANY AND STIFEL NOW PLAN
TO
FOCUS THEIR EFFORTS ON ALLN-346
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allena Pharmaceuticals
See all newsBrief: Allena Pharmaceuticals Inc - On September 6, Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On September 8, 2022
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
Allena down on bankruptcy filing